Compare HSAI & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HSAI | PBH |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.4B |
| IPO Year | 2021 | 2004 |
| Metric | HSAI | PBH |
|---|---|---|
| Price | $17.11 | $50.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $31.58 | ★ $75.33 |
| AVG Volume (30 Days) | ★ 1.4M | 546.9K |
| Earning Date | 05-19-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $975,777,000.00 |
| Revenue This Year | $46.29 | N/A |
| Revenue Next Year | $41.32 | $4.31 |
| P/E Ratio | ★ $61.18 | $82.03 |
| Revenue Growth | N/A | ★ 36.77 |
| 52 Week Low | $14.29 | $42.62 |
| 52 Week High | $30.85 | $71.07 |
| Indicator | HSAI | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 47.50 | 49.04 |
| Support Level | $14.46 | $47.61 |
| Resistance Level | $19.29 | $55.99 |
| Average True Range (ATR) | 0.76 | 1.82 |
| MACD | 0.03 | -0.32 |
| Stochastic Oscillator | 40.77 | 25.57 |
Hesai Group is engaged in the development, manufacture, and sales of three-dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with enhanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. Geographically, the company operates in North America, Mainland China, Europe, and Other regions.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.